Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer.
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer. Cells. 2020 09 17; 9(9).
View in:
PubMed
subject areas
Antigens, Neoplasm
Biomarkers, Tumor
Clinical Decision-Making
Disease Management
Gene Expression
Humans
Kallikreins
Male
Models, Statistical
Neoplasm Proteins
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Prostate
Prostatectomy
Prostate-Specific Antigen
Prostatic Neoplasms
Risk Assessment
authors with profiles
Gladell P. Paner